Joshua Gear
Neurology · Portsmouth, NHNPI 1821132069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 209 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 27.7% of the total.
Across 209 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$905
- Axsome Therapeutics, Inc.$802
- Corium, LLC$452
- Ironshore Pharmaceuticals Inc.$284
- E.r. Squibb & Sons, L.L.C.$252
- Collegium Pharmaceutical, Inc.$246
- plus $330 from 5 others
What the payments were for
- Food & beverage$3,25599%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 76 | $905 |
| Axsome Therapeutics, Inc. | 51 | $802 |
| Corium, LLC | 37 | $452 |
| Ironshore Pharmaceuticals Inc. | 14 | $284 |
| E.r. Squibb & Sons, L.L.C. | 2 | $252 |
| Collegium Pharmaceutical, Inc. | 15 | $246 |
| Johnson & Johnson | 1 | $111 |
| Supernus Pharmaceuticals, Inc. | 7 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Shire North American Group Inc | 2 | $46 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COBENFY$252
- Auvelity$230
- VRAYLAR$122
- INVEGA SUSTENNA$111
- INVEGA TRINZA$111
How this compares
$3,272 in reported general payments places this provider in the 80th percentile of 92 neurology providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $13,449 |
| VyvanseLisdexamfetamine Dimesylate | 16 | $6,521 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 23 | $4,392 |
| Lisdexamfetamine Dimesylate | 11 | $2,937 |
| Bupropion XlBupropion Hcl | 67 | $2,852 |
| Clozapine | 22 | $2,531 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 57 | $2,211 |
| Aripiprazole | 35 | $1,576 |
| Escitalopram Oxalate | 104 | $1,464 |
| Clonazepam | 129 | $1,361 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 37 | $1,321 |
| Sertraline Hcl | 42 | $726 |
| Divalproex Sodium | 26 | $679 |
| Guanfacine Hcl ErGuanfacine Hcl | 12 | $527 |
| Bupropion Hcl SrBupropion Hcl | 28 | $511 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $802 | $13,44912 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $51 | $6,52116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 92 neurology providers in New Hampshire.
Other neurology in Portsmouth
- Ann CabotManchester$622K
- Oliver PhillipsLebanon$50K
- Andrew PachnerLebanon$31K
- Jeffrey RindDerry$27K
- Uladzimir LuchanokDerry$21K
- John RescignoDerry$20K
- Jeffrey CohenLebanon$18K
- Jacob KaufmanNashua$17K
- Jianhui ZhangLebanon$12K
- Chad MeshbergerConcord$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.